Ventas (FRA:VEN) Loans Receivable: €137 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:VEN Ventas Inc FRA:VEN
81 GF Score
Price €83.04
GF Value €61.58
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Ventas Loans Receivable?

Ventas FRA:VEN +3.67% 81 Loans Receivable is €137 Mil as of Mar. 2026. GuruFocus rates FRA:VEN with a GF Score™ of 81/100 and a GF Value™ of €61.58 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Ventas's Loans Receivable for the quarter that ended in Mar. 2026 was €137 Mil.

Ventas's quarterly Loans Receivable declined from Sep. 2025 (€173.28 Mil) to Dec. 2025 (€140.69 Mil) but then stayed the same from Dec. 2025 (€140.69 Mil) to Mar. 2026 (€136.80 Mil).

Ventas's annual Loans Receivable increased from Dec. 2023 (€49.65 Mil) to Dec. 2024 (€165.22 Mil) but then declined from Dec. 2024 (€165.22 Mil) to Dec. 2025 (€140.69 Mil).

Ventas Loans Receivable Historical Data

* Premium members only.

The historical data trend for Ventas's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ventas Loans Receivable Chart

Ventas Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 486.00 529.97 49.65 165.22 140.69

Ventas Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 158.01 177.36 173.28 140.69 136.80
FRA:VEN
81GF Score
Ventas Inc FRA:VEN
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ventas Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of €137 Mil mean?
Ventas (FRA:VEN) has a Loans Receivable of €137 Mil as of Mar. 2026. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Ventas and its competitors.
Is Ventas' Loans Receivable too high?
Ventas' current Loans Receivable is €137 Mil. Overall, Ventas has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ventas' Loans Receivable compare to DOC and OHI?
Ventas' Loans Receivable of €137 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a REITs company?
A good Loans Receivable depends on the REITs industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Ventas and its competitors. Ventas's current Loans Receivable is €137 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ventas stock overvalued right now?
Based on GuruFocus' analysis, Ventas (FRA:VEN) is currently considered Significantly Overvalued. The stock's GF Value™ is €61.58, compared to a current price of €83.04 — trading 34.8% above its estimated fair value. The current Loans Receivable is €137 Mil. Ventas' overall GF Score™ is 81/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For Ventas (FRA:VEN), the current Loans Receivable is €137 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ventas (FRA:VEN) Overvalued in 2026?

Based on GuruFocus' analysis, Ventas stock appears to be overvalued. The current stock price of €83.04 is trading 34.8% above its estimated GF Value™ of €61.58. GuruFocus considers Ventas to be Significantly Overvalued.

Key valuation signals for FRA:VEN:

  • Loans Receivable: €137 Mil
  • GF Value™: €61.58 vs. price of €83.04 (34.8% above fair value)
  • GF Score™: 81/100 with 9 warning signs

No single metric tells the full story. See the FRA:VEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ventas Business Description

Industry Real EstateREITs
Address 300 North LaSalle Street, Suite 1600, Chicago, IL, USA, 60654
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
81GF Score

Get the complete analysis for FRA:VEN

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€83.04
Price
€61.58
GF Value